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Rifampicin resistant (Rif mutations map in the rpoB gene encoding the /? subunit of Escherichin 
coli RNA polymerase. We have used our collection of 17 sequenced Rif’ mutations to 
investigate the involvement of E. coli RNA polymerase in the antitermination systems 
enhancing expression of delayed early 2 genes or stable RNA. We have found that Rif’ 
mutations affect both 1 N-mediated antitermination and the cellular antitermination 
system involved in synthesis of stable RNA. Because NusA is involved in antitermination 
and termination, we also investigated the interaction of NusA and RNA polymerase by 
determining whether Rif * mutations alter NusA-dependent termination or antitermination 
in cells with defective nusA alleles. We have shown that Rif’ mutations can either enhance 
or suppress the phenotypes of defective nusA alleles. Most Rif’ mutations alter the 
temperature range over which the nusA1 allele supports I N-mediated antitermination. In 
addition, a number of Rif’ alleles restore termination to the nusAZO(Cs) and the 
nusAII(Ts) mutants defective in this process. Our results indicate that the region of the 
rpoB gene defined by the Rif’ mutations is involved in the antitermination process and 
affects the activity of the NusA protein directly or indirectly. 
1. Introduction 
Antitermination of t’ranscription was first 
identified as an important genetic regulatory 
mechanism from studies on bacteriophage 1 (for a 
review. see Friedman & Gottesman, 1983; Friedman 
et al., 1984). Progression through the 1 life cycle is 
controlled by two successive antitermination 
events, each of which enhances the transcription of 
genes downstream from terminators. The first 
antitermination event, mediated by ilN protein, 
results in increased expression of the 2 DNA 
replication genes and the Q gene while the second, 
mediated by the Q protein, allows expression of the 
genes coding for host lysis and structural com- 
ponents of the bacteriophage. 
The involvement of Escherichia coli proteins in 
N-mediated antitermination has been investigated 
both genetically and biochemically. The Nus 
mutants identify a group of genetic loci that encode 
gene products involved in N-mediated antitermina- 
tion (for a review, see Friedman & Gottesman, 
1983). Nus mutants do not allow wild-type L to 
grow but permit the growth of J. N-independent 
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derivatives such as Anin5. The nin5 deletion 
removes the strong terminators interposed between 
the 1Pa promoter and the Q structural gene thus 
eliminating or reducing the requirement for 
N-mediated antitermination. To date, five nus loci 
have been identified. The nusA locus encodes an 
acidic 54,000 M, protein that binds to core RNA 
polymerase with high efficiency (Friedman, 1971; 
Kung et al., 1975; Greenblatt & Li, 198la,b; Ishii et 
al., 19846). Functionally, NusA modulates elonga- 
tion and pausing (Kingston & Chamberlin, 1981; 
Greenblatt et al., 1981; Schmidt & Chamberlin, 
1984; Greenblatt, 1984; Lau et aE., 1983; Farnham et 
al., 1982; Fisher & Yanofsky, 1983; Landick & 
Yanofsky, 1984) and participates in both termina- 
tion and antitermination (Greenblatt et al., 1981; 
Ward & Gottesman, 1981; Nakamura et al., 1986a,b; 
Schmidt & Chamberlin, 1987; ChamberlinetaZ., 1987). 
The nusB locus encodes a very basic 15,000 Mr protein 
(Swindle et al., 1981; Georgopoulos et al., 1980; 
Strauch & Friedman, 1981; Ishii et al., 1984a). The 
other three nus alleles are in previously identified 
genes: nusC mutation map in rpoB (Friedman et al., 
1984), encoding the /l subunit of RNA polymerase; 
nusD mutations map in rho (Simon et al., 1979) 
encoding the transcription termination factor Rho 
and the nusE mutation (Friedman et al., 1981) alters 
rpsJ, encoding ribosomal protein SIO. Recently, a 
23,000 ilf, E. coli protein called NusG was identified 
biochemically (Horwitz et aZ., 1987). The NusA, 
NusB, SlO and NusG proteins, in concert with N 
protein, modify host RNA polymerase at nut sites 
(Friedman et al., 1973; Adhya et al., 1974; Franklin, 
1974; Salstrom & Szybalski, 1978; Rosenberg et aZ., 
1978; de Crombrugghe et al., 1979; Das & Wolska, 
1984; Goda & Greenblatt, 1985; Greenblatt et al., 
1986; Barik et al., 1987; Horwitz et al., 1987) 
rendering transcription resistant to termination at 
some, but not all, downstream terminators. The nut 
sites are likely to be recognized in the transcript 
and contain a stem and loop structure called boxB 
required for N-entry, as well as the octamer 
sequence CGCTCTTA called boxA (Salstrom & 
Szybalski, 1978; Friedman & Olson, 1983; Warren 
& Das, 1984; Olson et al., 1984; Peltz et al., 
1985). 
The extensive involvement of host proteins in 
N-mediated antitermination suggests that 
antitermination might also be involved in host gene 
expression. In fact, expression of stable RNA has 
been found to be dependent upon an antitermina- 
tion system, presumably to prevent termination at 
Rho-dependent terminators and other terminators 
that exist in the nascent non-translated stable RNA 
transcripts (Aksoy et al., 1984; Li et al., 1984; 
Holben & Morgan, 1984; also reviewed by Morgan, 
1986). This antitermination system shares some 
components with N-mediated antitermination. 
E. coli carrying nusB5 mutations are defective in 
both antitermination systems (Sharrock et al., 
1985). In addition, both types of antitermination 
seem to involve the bozA sequence (Li et al., 1984). It 
is likely, although it has not been demonstrated 
conclusively, that NusA is involved in cellular 
antitermination (Sharrock et al., 1985). 
Little is known about the intrinsic terminating 
capacity of RNA polymerase or the nature of the 
interaction of RNA polymerase with the anti- 
termination apparatus or with NusA. One way to 
probe these interactions is to examine the effect of 
RNA polymerase mutations on these processes. 
Mutations leading to rifampicin resistance map in 
rpoB and some are known to affect the 2 
antitermination process and other events involving 
the NusA protein (Georgopoulos, 1971; Ghysen & 
Pironio, 1972; Sternberg, 1973). The Rif’ mutant, 
rif501, confers partial N-independence and also 
affects the ability of RNA polymerase to terminate 
at NusA-dependent terminators (Lecocq & Dambly, 
1976; Greenblatt et al., 1981). Other rifampicin- 
resistant (Rif’) mutations are reported to enhance 
the antitermination defect of cells containing the 
nusA1 mutation (Sternberg, 1976; Baumann & 
Friedman, 1976). However, there has been no 
systematic study of the effects of Rif’ mutations on 
antitermination of nusA mutants. 
We have identified 17 rifampicin-resistant (Rif ‘) 
mutations, affecting 14 different amino acids in the 
middle of the /I subunit, many of which alter the 
ability of RNA polymerase to terminate in viva at 
Rho-dependent or Rho-independent terminators (Jin 
& Gross. 1988; Jin et al., 1988). Based upon t’he 
number of identical isolates at each position, we 
have argued that this set of mutations is likely to 
include most of the Rif’ mutations viable in haploid 
cells (Jin & Gross, 1988). We report the effects of 
each of these Rif’ mutations on A N-mediated and 
cellular antitermination. Because of the involve- 
ment of NusA in these antitermination processes as 
well as in termination, we also specifically ask about 
the interaction of RNA polymerase with NusA. We 
determine whether any of the Rif’ mutations alter 
NusA-dependent antitermination and termination 
in cells with defective nusA alleles. Our results 
indicate that the Rif’ mutations affect antiter- 
mination and they either enhance or suppress the 
phenotypes of defective nusA mutants. Some of the 
effects on antitermination may be due to effects on 
termination capabilities, whereas other effects on 
antitermination may be due to altered interactions 
with NusA. These results suggest that the region of 
the fl subunit defined by the RiP mutations is 
involved in the antitermination process and affects 
the activity of NusA protein either directly or 
indirectly. 
2. Materials and Methods 
(a) Bacterial strains, bacteriophage and plasmids 
A description of the Rif mutations used in this study 
and the strains employed for measuring their phenotypes 
are presented in Table 1. In every case, the Rif’ alleles 
were introduced into the strains by cotransduction with a 
linked TnlO marker as described (Jin & Gross, 1988). The 
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Table 1 
Strains used in this study 
Strain Relevant genotype Source/reference 
MG1655 E. coli K12 wild-type su’ CGSC 
CAG3307 nusA1 derivative of MG1655 This work 
N5261 SABOOhis ilv gaZE490 (chZD-blu)bs(lARAM N ‘~114 AH) Ward et al. (1983) 
N5283 Same as N5261 except LABAM carries Kant mutations M. Gottesman 
CAG8333 nusAf derivative of N5261 M. Singer 
K37 galK2 rpsL200 CGSC 
K1914 nusAIO(Cs) derivative of K37 Schauer et al. (1987) 
CAG8102 rpsL+ derivative of K37 M. Singer 
CAG3844 nu.sAlO(Cs) derivative of CAG8102 This work 
CAG3846 nusAII(Ts) derivative of CAG8102 This work 
YN2458 R.594 nusAIl(Ts) Nakamura et al. (1986a) 
Rif’ (rpoB) 
allele Amino acid residue affected Amino acid change 
3445 A(507751 1) A Gly, Ser, Ser, Gln, Leu 
and inserts Val 
101 513 Gln to Leu 
8 513 Gln to Pro 
113 516 Asp to Asn 
148 516 Asp to Val 
3051 517 Insert Gln and Asp 
3595 522 Ser to Phe 
2 526 His to Tyr 
3401 529 Arg to Cys 
3402 529 Arg to Ser 
114 531 Ser to Phe 
3449 A532 AAla 
3443 533 Leu to Pro 
3370 563 Thr to Pro 
111 564 Pro to Leu 
7 572 Ilv to Phe 
3406 687 Arg to His 
efficiency of 1 plating (e.0.p.t: see below) was determined 
in Rif’ derivatives of MG1655 and CAG3307. N-mediated 
antitermination was assayed in Rif r derivatives of N5261 
and CAG8333. Cellular antitermination was assayed in 
Rif’ derivatives of CAG8102 carrying plasmid pES3 
(described below). The effect of the Rif’ mutations on the 
termination efficiency of nusAIO(Cs) and nusAII(Ts) was 
determined in Rif’ derivatives of K1914 and CAG3846 
carrying pES4 (described below), respectively. 
Bacteriophage 1+, aNam and Inin5 were from 
W. Dove. 
Plasmid pKG 1800 contains promoter P,, inserted 
upstream from the galK structural gene, while pKG1810 
contains the terminator T,,, interposed between P,,, and 
gaZK. Both plasmids were obtained from K. McKenney 
and derived from plasmid pKO1 (McKenney et al., 1981). 
(b) Construction of pES3 and pES4 
Plasmids pES3 (see Fig. 2) and pES4 (see Fig. 3) were 
constructed to allow measurement of rrnA transcription 
antitermination activity by comparative measurements 
of galK gene expression. Both plasmids contain the 
strong rrnA Pl promoter transcribing the g&K gene with 
2 tandem transcriptional terminators (rmB Tl and T,,,) 
interposed to dampen gaEK expression to the point where 
colony color on galactose MacConkey plates is sensitive to 
t Abbreviations used: e.o.p.. efficiency of plating; Cs, 
cold-sensitive; Ts. temperature-sensitive; bp, base- 
pair(s). 
the presence of a modified boxA region in pES3. Both 
plasmids were derived from a pKG1800 plasmid con- 
taining an IS2 terminator in the S’maI site 180 bp 
upstream from the ATG of the gaZK gene (McKenney et 
al., 1981). The pES3 and pES4 plasmids were constructed 
by replacing the EcoRI-Hind111 gal promoter fragment 
of pKG1800-IS2 with various portions of a pPS1 plasmid 
(or its subclones) that contains a fusion between the rrnA 
promoter region and the rrnB terminator region 
(Sarmientos et al., 1983). The rrnA PI promoter is on an 
EcoRI-Hind111 fragment containing sequences from 
-262 to +31 (relative to the RNA start site). The rrnB 
Tl terminator was inserted as a Hind111 fragment 
(containing positions 2418 to 2607 of Brosius et al., 1981). 
In pES3, but not pES4, a modified boxA region fragment 
spanning positions 1347 to 1426 of Brosius et al. (1981) 
was obtained from pPS1 subclones that contained a T to 
G change at position 1379 and a deletion of 3 bases (ATC) 
at positions 1390 to 1392. These spontaneous changes 
result boxA 
TGCTdiTTA:CAATTT - -rgf.. 
sequence of 
which permits 
less read&rough than the wild-typi boxA sequence 
(M. Cashel, unpublished). Nonetheless, the presence of 
this modified boxA fragment in pES3 enables galK 
expression despite the presence of 2 otherwise highly 
efficient terminators in wild-type hosts (see Results). 
(c) General bacterial and bacteriophage 
techniqldes and media 
Cells were grown in MS-glucose complete medium (M9- 
glucose supplemented with amino acids, nucleosides and 
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vitamins) (Miller, 1972), NZY medium + maltose 
(Maniatis et al., 1982) or LB (Miller, 1972). LB, NZY and 
MacConkey-galactose plates were made as described by 
Miller (1972) or Man&is et al. (1982). Tetracycline 
(10 pg/ml), ampicillin (50 pg/ml) and rifampicin 
(50 pg/ml) were added when indicated. 
Competent cells were prepared by the Cazt shock 
method following growth in LB (Mandel & Higa, 1970) 
and were stored at - 70°C. Transformations were 
performed as described by Morrison (1979) and trans- 
formants were plated on selective plates after outgrowth 
for 2 h. 
Bacterial growth was followed by measuring a change 
in optical density at 450 nm (minimal medium) or 600 nm 
(broth). 
Pl transductions were performed as described by Miller 
(1972). 
(d) Ejiciency of 1 plating (e.o.p.) 
Cells (0.1 ml) of a fresh overnight culture grown on 
NZY + maltose were infected with about 5 x lo3 i phage. 
Following adsorption at 37 “C for 15 min, cells were plated 
with 3 ml of NZY top soft agar on prewarmed fresh NZY 
plates. Plates were incubated overnight at the indicated 
temperature and 1 plaques were counted. When the e.o.p. 
was within a factor of 2 of that exhibited by wild-type 
cells, the strain was considered permissive for 1 growth. 
Strains unable to grow 2 exhibited an e.o.p. of 2 x 1O-4 or 
lower. 
(e) Enzyme assays 
Galactokinase (GalK) activity was measured from cells 
grown in MS-glucose complete medium using the assay 
described by McKenney et al. (1981) except that sodium 
deoxycholate (0.3%, w/v) was present in the lysis buffer. 
GalK activity is expressed as a differential rate of 
synthesis and is calculated from the slope of the line 
generated when enzyme activity is plotted rer8u.y cell 
growth. The slopes reported were based on samples taken 
at 3 to 4 times durin 
4 
log phase growth and are 
calculated as cts/min x 10 Gal-P04/A4,s normalized to a 
reaction mixture containing 8 pCi/pmol [‘4C]galactose. A 
slope of 1000 cts/min Gal-PO,/A,,, is defined as 1 1’. 
Every differential rate was determined at least twice. 
Duplicate determinations deviated less than 2504 from 
the average value. When the galK gene was carried on a 
plasmid, the differential rate of synthesis was divided by 
the /J-lactamase activity determined as described by 
Tomizawa (1985) to correct for copy number differences 
between strains. The /%lactamase activity was 
determined in duplicate on one of the lysates used for 
measuring the differential rate of galactokinase synthesis. 
We verified that the /?-lactamase activity measurements 
were an accurate reflection of copy number by 
quantifying copy number by hybridization with “P- 
labeled pES4 as described by Adams & Hatfield (1984). 
The relative copy number measurements obtained by dot 
blots analysis agreed with that obtained from 
p-lactamase assay (D. J. Jin. unpublished results). 
VI 81 mapping 
We used the Si nuclease method of Berk & Sharp 
(1978) to compare the fraction of transcripts that read 
through terminators in pES3 or pES4 following initiation 
at promoter rrnA Pl. Total E. coli RNA was prepared 
from mid-log cultures (A450nm = 0.5) growth at 37°C in 
Is2 w (A8 h-@B44) A <AHI 
K T  E OPgal t N nut PL cl 
IW 
&I+ A N actwe 
Figure 1. P,-gal fusion. The lambda P, promoter is 
contained on a cryptic prophage located close to the 
E. coli gal operon. Deletions ABAM and AHI remove all i 
genes with the exception of N, rex, and CT. The c1 
repressor gene is inactivated by the ~114 mutation. 
thereby allowing constitutive leftward transcription from 
P, towards the nearby E. coli gal operon. The only I gene 
expressed is N. Expression of gal from its cognate 
promoter is prevented by the gaZEdSO mutation, an IS2 
insertion in the leader region that causes termination of 
transcription. When the AN function is active, 
transcription from P, is insensitive to the termination 
signals oft and IS2 enabling expression of the gal operon. 
To maximize expression of gal, the gal operon was 
brought closer to the P, promoter by the large 
chromosomal deletion &IL-hZuAs (adapted from Ward rt 
al.. 1983, with permission). 
MS-glucose complete medium + ampicillin by the hot 
phenol extraction method of Salver et al. (1967). 
RNA/DNA hybridization conditions were those used by 
Berk C Sharp (1978). All hybridizations were done with 
excess DNA. RNA samples (adjusted to 1OOpg of RNA 
per sample with tRNA) were hybridized to labeled DNA 
probe for overnight at 37”C, digested with S, nuclease 
(170 units/reaction: Boehringer-Mannheim) for 1 h at 
37°C. The S,-resistant DNA fragments were resolved on a 
120,” or 5O/, (w/v) polyacrylamide gel containing 507” 
(w/v) urea (Maxam & Gilbert, 1980). The experiments 
were quantified by measuring the radioactivity in DNA 
fragments cut from gels. Data for each transcript were 
based on duplicate determinations at several RNA 
concentrations. 
3. Results 
(a) Most Rif’ mutations affect 
Nmediated antitermination 
We used two different types of assays t,o 
determine whether any of the Rif’ mutations 
affected N-mediated antitermination. First, we 
examined the efficiency of plating (e.o.p.) of ;1 and 
several of its derivatives on the mutant strains (see 
Materials and Methods). We determined whether 
any of the Rif’ mutations affected the e.o.p. of A+, 
but not kin5 on lawns of either nusA+ or nusA1 
bacteria. Because A+ requires N-mediated antiter- 
mination for its lytic growth while Inin5 does not, 
bacterial strains able to grow hin5 but not i+ are 
likely to be defective in N-mediated antitermina- 
tion. In addition, we determined whether any Rif’ 
mutations render 1 growth independent of N by 
asking if any of the Rif’ mutations can support the 
growth of the ANam phage, which cannot express 
functional N protein in hosts lacking a suppressor 
tRNA. 
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Table 2 
rpoB3595 bypasses the requirement for N from LP, but not from IP, 
FB 
allele 
1Nan53 plaque formation 
in MG1655” 
32°C 4OO”C 
Expression of gaZK from 1P, 





- - so.5c 10.5 
- + so.5 so.5 
- - so.5 10.5 
’ +, permissive for phage growth; -, e.o.p. <2.0x 10e4 relative to that in nonsense-suppressing 
bacteria. 
b Values are expressed in GalK units as defined in Materials and Methods. 
‘A GalK value 10.5 is not distinguishable from the background value. 
d See Table 1. 
To determine the magnitude of these effects, we 
used a second assay in which the rate of galK 
synthesis reflected the extent of N-mediated 
antitermination. In strain N5261, expression of the 
gal operon is dependent on antiterminated tran- 
scripts originating from the 1P, promoter (Fig. 1). 
We transduced each of the Rif’ alleles into N5261 
and CAG8333 (N5261 nusA1) and then measured 
galK expression to quantify the effect of each Rif 
mutation on N-mediated antitermination. 
(i) Bypass of the need for 
N-mediated antiterminution 
One Rif’ mutation, rpoB3595, allowed ilNam53 
to grow at 40°C but not 32°C indicating that it 
permitted 1 growth independent of N at high 
temperature (Table 2). The wild-type strain and 
other Rif’ mutants did not permit 1Nam53 to form 
plaques (Table 2). Interestingly, although transcrip- 
tion from 1P, (as assayed by 1 growth) is N- 
independent, transcription from 1P, as assayed by 
galK expression from AP, was not increased above 
the background in the rpoB3595 derivative of 
N5261N- (Table 2). The fact that expression from 
P, is not increased rules out the possibility that the 
A N-independent growth arises from partial 
suppression of the Nam defect in rpoB3595 strains. 
The $501 mutation has the same phenotype as 
rpoB3595 (Lecocq & Dambly, 1976). As discussed 
below, the sequence change leading to Rif, is 
shared between the two strains (Jin & Gross, 1988). 
(ii) Defects in N-mediated antiterminution 
in nusA+ strains 
Iz+ forms plaques on a strain containing the 
rpoBll1 allele only at high temperature (Table 3). 
The inability of a strain with the rpoBll1 allele to 
allow 1+ plaque formation at 32°C results from a 
defect in N-mediated antitermination since rpoBll1 
allows Inin plaque formation at 32 “C (Table 3). 
K. Hammer and M. Gottesman, who originally 
isolated the rpoB111 allele (which they called 
sck-2), have also found that it restricts A growth at 
low temperature (Hammer et al., 1987). Consistent 
with the A plaque formation phenotype, expression 
of galK in N5261 rpoBll1 was reduced tenfold at 
32°C (Table 3). Measurement of GalK indicated 
that the rpoBll1 strain is also defective in 
N-mediated antitermination at 42 “C, although the 
defect is apparently not severe enough to inhibit ,l 
growth (Table 3). rpoBll1 was the only RiP allele 
found to affect N-mediated antitermination in a 
nusA+ strain (Table 3). 
(iii) Alterations in N-mediated antitermination 
in nusA1 strains 
In nusA1 strains, N-mediated antitermination is 
defective at high temperature (Friedman, 1971; 
Table 3 
rpoB 111 inhibits 1 N-mediated antitermination in a nusA ’ strain 
rpoB 
allele 
1 Plaque formation in MG1655’ Expression of &dK from 
/I+ kin5 1 P, in N5261b 
32°C 42 “C 32 “C 42°C 32°C 42°C 
rpoB + + + + + 1.0 1.0 
111 - + + + 0.1 0.2 
Others’ + + + + d d 
’ + , permissive for phage growth; - , e.o.p. < 2.0 x 10e4. 
‘The GalK units (measured as described in Materials and Methods) in each of the mutant strains are 
expressed relative to the units in the rpoB+ strain, The GalK units for the rpoB+ strain at 32°C and 
42°C are 30.0 and 60.0 units, respectively. 
‘See Table 1. 
d GalK values for each of the other RiP mutants differed less than 2-fold from that of the wild-type 
strain. 
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Table 4 
Some Rif mutations interfered with I N-mediated antitermination in nusAl strains 
rpoB 
allele 
I Plaque formation 
in CAG3307 (MG1655 nusilZ)* 
32°C 36°C 
Expression of gaZK from LP, 
in CAG8333 (N5261 nu.sA~‘)~ 
32°C‘ 36°C’ 
rpoB+ + + 1.0 1.0 
3445 - - 0.1 0.1 
8 + - 0.3 0.3 
113 + - 0.3 0.2 
148 + - 0.6 0.3 
111 - - <O,l <O.l 
’ + , permissive for phage growth; - , e.o.p. < 2.0 x 10m4. 
bThe GalK units (measured as described in Materials and Methods) in each of the mutant strains are 
expressed relative to the units in the rpoB+ strain. The GalK units for the rpoB+ &rain at 32°C and 
36°C are 20.0 and 12.0 units, respectively. 
Friedman & Baron, 1974). Strains carrying the 
nusA1 allele allow 1 plaque formation normally at 
low temperature but are unable to allow I plaque 
formation above 37°C (Tables 4 and 5). We asked if 
any of the Rif’ alleles altered N-mediated antiter- 
mination in nusA1 strains. All but one Rif’ 
mutations altered the temperature range over which 
the N-mediated antitermination system was func- 
tional in nus.41 strains (Tables 4 and 5), suggesting 
that the Rif region of the p subunit plays an 
important role in modulating N-mediated 
antitermination. 
Five of the Rif’ mutations inhibited antitermina- 
tion in nusA1 strains. nusA1 strains containing 
these Rif’ mutations were unable to support 2 
plaque formation at 36°C (Table 4). Of these Rif’ 
mutants, two were unable to allow I plaque 
formation at 32°C. These five Rif’ nusA1 mutants 
all allowed Inin5 plaque formation at 32°C (II. J. 
Jin, data not shown) suggesting that the defect in i 
plaque formation reflected inability to carry out 
N-mediated antitermination. Measurement of GalK 
in N5261 nusA1 confirmed that these five Rif’ 
mutations decreased N-mediated antitermination 
(Table 4). These strains have reduced expression of 
galK at both 32°C and 36°C. Strains containing 
rpoBll1 and rpoB3445 that were most restrictive 
for L growth also showed the greatest reduction in 
gaZK expression. Comparison of the extent of N- 
mediated antitermination with the ability to allow 
L plaque formation indicates that II plaque 
formation is prevented (e.o.p. <2 x 10m4) when the 
amount of antitermination is reduced about tenfold 
from that in wild-type cells at 32°C. 
A total of 11 of the Rif’ mutations partially 
suppressed the nusA1 phenotype and permitted A 
Table 5 

















I Plaque formation Expression of galK from LP, 
in CAG3307 (MG1655 nusAI) in CSG8333 (N5261 TUUSAI)~ 
- ~~~ .~ 
32°C‘ 38 Y’ 32 “(‘ 38 “( 1“‘(’ 
+ - 1 ,o 1.0 I.0 
+ + 1.2 5.1 12.0 
+ + 0.9 2.7 24 
+ + 0.i 2.3 4.0 
+ + 0.6 5.1 30.0 
+ + 1 ,ti 3.3 5.4 
+ + 1.8 5.8 c 
+ + 0.X 2.2 34 
+ + 14 2.2 4.0 
+ + 1.2 1.8 24 
+ + 2.4 7.3 234 
+ + 0.8 1.7 2.4 
+ + 2.3 5.1 8.0 
a + , permissive for phage growth; -, e.o.p. <2.0 x lo-? 
bThe GalK units (measured as described in Materials and Methods) in each of the mutant strains are 
expressed relative to the units in the rpoB* strain. The GalK units for the rpoB+ strain at 32”C, 38°C 
and 42°C are 20.0, 4.8 and 10.5 units, respectively. A GalK value go.5 is not distinguishable from 
the background value. 
‘The strain containing rpoB3401 was unable to grow at 42”C!. 
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plaque formation at 38°C (Table 5). These same 
mutations also caused increased galK expression at 
38°C in N5261 nusA1 (Table 5). This effect was 
dependent upon a functional N; in the absence of N, 
galK expression was undetectable (D. J. Jin, data 
not, shown). Since these Rif’ alleles have little (<2- 
fold) effect on galK expression in the N5261 nusA+ 
strain, they are unlikely to affect initiation from the 
P, promoter (D. J. Jin, data not shown). Therefore, 
we conclude that the increased galK expression of 
these 11 Rif’ mutations results from increased 
antitermination. Among these 11 strains, some 
showed significant enhancement of galK expression 
even at 42°C. Two alleles, rpoBlO1 and rpoB3370, 
had the greatest effects and increased N-mediated 
antitermination 10 to 20-fold in nusA1 strains at 
this temperature (Table 5). 
We present the nusA1 suppression data for rif501 
in Table 5 because these data suggested to us that 
rif501 has more than one mutation. The rif501 
mutation is identical with that in rpoB3595 within 
the 200 bp region sequenced to ascertain the 
mutational change conferring Rif’ (Jin & Gross, 
1988). The phenotypes of these strains were also 
identical (D. J. Jin, unpublished data) except when 
we examined the nusd suppression phenotype. The 
expression of galK is about sevenfold higher at 42 “C 
in CAG8333 rif501 than in the CAG8333 rpoB3595 
isogenic strain (Table 5). The mutation rpoB3595 
arose spontaneously (J. Gardner, personal 
communication) while rif501 was obtained after 
nitrosoguanidine mutagenesis (Lecocq & Dambly, 
1976). The enhanced suppression of the nusA1 
defect by rif501 could be explained if this strain 
carries additional mutations outside of the Rif 
region of rpoB. 
(b) The effects of Rir mutations on the 
cellular antitermination system 
We used the pES3 vector described in Materials 
and Methods to determine whether any of the RIP 
mutations affected the cellular antitermination 
system involved in transcription of stable RNA. In 
pES3, sequences derived from the rrnA operon, 
including a boxA site, allow transcription through 
the strong rrnT1 and IS2 terminators resulting in 
expression of galK. When the pES3 plasmid is 
carried in a galK- strain, alterations in the amount 
of antitermination were detected as altered 
expression of galK. 
Rif’ derivatives of CAG8102, a galK- strain, 
were transformed with pES3 and screened on 
MacConkey-galactose-ampicillin plates (MGA 
plates) to determine whether they decreased galK 
expression from pES3. Most of the Rif’ mutants 
gave the expected Gal+ phenotype and had GalK 
activity similar to that in the rpoB’ strain (data 
not shown). However, three Rif’ mutants, rpoBll4, 
rpoB3449 and rpoB3443 were Gal- when trans- 
formed with pES3. The rate of galK expression in 
these strains was about tenfold lower than in 
the isogenic rpoB’ parental strain (Table 6). 
Table 6 
Some Rifr mutants are defective in cellular 
antitermination 





















‘The GalK units (measured as described in Materials and 
Methods) in each of the mutant strains are expressed relative to 
the units in the rpoB+ strain. The value in parentheses indicates 
the value of GalK units in the rpoB+ strain. 
bSee Table 1. 
’ GalK values for each of the other mutants differed less than 
2-fold from that of the rpoB+ strain. 
Interestingly, these were the only three Rif’ alleles 
that do not affect any of the Rho-dependent or 
Rho-independent terminators we have assayed (Jin 
et al., 1988). 
The decreased expression of galK in strains 
containing these three Rif’ mutants could result 
either from decreased initiation at rrnA Pl or from 
increased termination at one or both of the 
terminators located upstream of galK in pES3. To 
distinguish these possibilities, we “S, mapped” in 
vivo RNA originating from rrnA Pl, using a probe 
that was 5’-end-labeled at the HindIIT site (see 
schematic in Fig. 2). We found that the initiated 
transcript represents a similar fraction of total 
RNA in the rpoB+ and the three Rif’ mutant 
strains indicating that initiation at promoter Pl is 
not affected by the Rif’ mutations (Fig. 2(a)). 
A further S, mapping experiment using a probe 
5’.end-labeled at the SnaBl site downstream from 
the terminators (see schematic in Fig. 2) indicated 
that these three Rif’ mutants decreased read- 
through of the pES3 terminators at least tenfold 
(Fig. 2(b)). These results indicate that the dramatic 
decrease in galK expression results from the fact 
that these three Rif’ mutations decrease the 
effectiveness of the cellular antitermination system 
involved in the synthesis of stable RNA. 
(c) The nusAlO(Cs) mutation affects 
termination in pES4 
Plasmid pES4 differs from pES3 in that it lacks 
the boxA sequence necessary for antitermination. 
Expression of galK in cells carrying pES4 is very 
low because transcription stops at the rrnT1 and 
T,s2 terminators upstream from the galK structural 
gene. None of the Rif’ mutations increased 
expression of galK from pES4 (data not shown). 
However, the nusAIO(Cs) mutation, which 
prevents cell growth at 30°C and decreases the 
efficiency of the N-mediated antitermination system 
(Schauer et al., 1987), does affect galK expression 
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(b) 
Figure 2. S, nuclease mapping of the transcripts from rrnA Pl in pES3 to analyze cellular antitermination in wild- 
type and 3 RiP mutant strains. The schematic (not drawn to scale) outlines the strategy for mapping the transcripts 
initiating from rrnA Pl and the transcripts that readthrough both the Tl and T,,, terminators. The mRNA transcripts 
are indicated with an arrowhead. The 5’-end-labeled [32P]DNA fragment (32P indicated by *) used for hybridization is 
shown above the respective mRNA transcript. (a). Total transcripts initiating from rrnA Pl. A 410 bp HindIII-BcoRI 
fragment 5’ end-labeled at the Hind111 site was hybridized with increasing amounts of RNA extracted from rpoB+(A), 
rpoBl14 (m), rpoB3449 (+), or rpoB3443 (@), digested with Si nuclease and electrophoresed on a 5% (w/v) 
polyacrylamide gel containing 50% (w/v) urea. The radioactivity in the protected fragment (110 bp) was quantified by 
counting the excised fragment in 5 ml of scintillation fluid (EcoLite). The amount of transcript hybridized is plotted 
versus increasing amount of total cellular RNA. (b). Transcripts extending beyond terminators rrnB Tl and T,s2. 
A 1100 bp XnaBI-EcoRI fragment 5’-end-labeled at the SnaBI site was used for hybridization with RNA from the 
rpoB+(&, rpoBl14 (w), rpoB3449 (+), or rpoB3443 (a). After S, nuclease digestion and electrophoresis on a 5% (w/v) 
polyacrylamide gel containing 50% ( w v  urea, the protected fragment was quantified by measuring the radioactivity in / ) 
the fragment. The amount of transcript hybridized is plotted versus increasing amounts of total cellular RNA. 
from plasmid pES4. When pES4 is carried in strains 
containing nusAZO(Cs), the cells are red on MGA 
plates and expression of galK is at least tenfold 
higher than in isogenic nusA+ strains at 37 “C 
(Table 7). In fact, the level of gaZK expression from 
pES4 in nusAlO(Cs) cells is comparable to that of 
pES3 in nusA+ cells (compare Tables 6 and 7). 
The increased expression of galK from pES4 in 
the nusAlO(Cs) strain resulted either from increased 
initiation a.t rrnAP1 or from increased readthrough 
of one or both of the terminators located upstream 
from galK in pES4. To distinguish t&se possibilities, 
we used S1 mapping of in vivo RNA. We measured 
total RNA initiated from promoter Pl of rrnA by 
S, mapping with a probe that was 5’-end-labeled at 
the Hind111 site and readthrough RNA using a 
probe that was 5’.end-labeled at the SnuBI site 
located downstream of both terminators (Fig. 3). 
We found that the initiated transcript represents a 
similar fraction of total RNA in the nusAZO(Cs) and 
nusA + strains indicating that initiation at 
promoter PI is not significantly affected by the 
nusAZO(Cs) mutation (Fig. 3(a)). In contrast, read- 
through RNA is about 15 times more abundant in 
the nusAlO(Cs) strain than in the nusA+ strain 
(Fig. 3(b)). This result indicated that the 
nusAlO(Cs) allele is altered in terminator read- 
through rather than initiation. 
The pES4 plasmid might contain cryptic boxA 
sites. In this case, the increased terminator 
readthrough by the nusAlO(Cs) allele could result 
from increased antitermination at cryptic boxA sites 
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Table 7 
Some Rif mutations suppress the termination defects of nusA mutants, as measured 
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In the rpoB+ nu.sA+ strains containing pES4, GalK is 5.0 units (measured as described in Materials 
and Methods) and cells are white on MGA plates. 
’ Assaved at 37 “(1. 
b Assaied at 30 “C. 
’ The GalK units (measured as described in Materials and Methods) in each of the mutant strains are 
exnressed relative to the units in the rpoB+ strain. The value in parentheses indicates the value of 1 
. GalK units in the rpoB+ strain. 
dThis double mutant grew too poorly to be assayed. 
‘See Table 1. 
’ GalK values for the other Rif mutants differed less than 2-fold from that of the rpoB+ strain. 
rather than from decreased termination at one or 
both of the terminators. To distinguish between 
these possibilities we asked if the nusAZO(Cs) allele 
can decrease termination of transcripts initiated 
from Pgol that do not contain a boxA sequence. 
Plasmid pKG1810 contains T,s2 interposed between 
P ga, and galK. GalK expression is significantly 
higher in the nusAlU(Cs) cells containing pKG1810 
than in the isogenic wild-type cells (Fig. 4(a)). The 
effect of the ,nusAlO(Cs) allele on readthrough of 
T,,, from P,, is at least fivefold but could be much 
greater. We cannot calculate the magnitude of the 
effect since expression of gaEK in the nusA+ strain 
containing pKG 1810 is not significantly different 
from the background value for the assay (see legend 
to Fig. 4), and we cannot reliably measure 
terminator readthrough in the nusA+ control. 
Increased gaZK expression in the nusAlO(Cs) strain 
does not result from increased initiation at Pgal. 
galK expression is virtually identical in nusA+ and 
nusA ZO(Cs) strains containing the control plasmid 
pKG1800 lacking the terminator (Fig. 4(b)). 
Taken together, these experiments establish that 
the nusAlO(Cs) strain has a defect in termination at 
some terminators. Our conclusion that nusAZO(Cs) 
is defectrive in termination is consistent with recent 
work of Schmidt & Chamberlin (1987) indicating 
that termination at rmT1. one of the two 
terminators present in pES4, is nusA-dependent in 
vitro. 
(d) Some Rif’ mutations affect termination 
in nusA mutant strains 
We determined whether any of the Rif’ muta- 
tions suppressed the termination defect of the 
nusAlO(Cs) strain at the terminators present in 
pES4. A total of seven of the Rif’ mutations 
suppressed this defect to some extent (Table 7). 
Among these, the three Rif’ mutations depressing 
cellular antitermination showed virtually complete 
suppression. These nusAlO(Cs) Rif’ mutants are 
white on MacConkey-galactose plates and have the 
same low level of gaZK expression from pES4 as 
does nusA+ (Table 7). These data indicate that a 
number of the Rif’ alleles significantly restore the 
ability of this mutant NusA protein to carry out 
termination. 
The nusAll(Ts) allele prevents cell growth at 
high temperature, is altered in N-mediated antiter- 
mination and has been shown to be defective in 
termination at several terminators in viva 
(Nakamura et aZ., 1986u,b). The level of gaZK 
expression in nusAII(Ts) cells containing pES4 is 
similar to that in nusAlO(Cs) cells, indicating that 
nusAIl(Ts) is also defective in termination at pES4 
terminators (Table 7). We tested the Rif mutations 
to determine if any suppressed the nusAlZ(Ts) 
termination defect. Of the seven Rif’ alleles that 
decreased galK expression in the nusAlO(Cs) strain, 
five also decreased galK expression in the 
nusAlZ(Ts) strain. There were no alleles that 
suppressed nusAlZ(Ts) that, did not also suppress 
nusAlO(Cs). 
Two of the Rif’ alleles, rpoB3595 and rpoB2, are 
incompatible with nusAZO(Cs) and nusAll(Ts) at 
3O”C, 37°C and 40°C while bacteria carrying 
rpoB3401 and either nusA mutation grow 
extremely poorly (D. J. Jin, data not shown). These 
three Rif’ mutations are located near each other. 
Each of these Rif’ mutations permitted a great 
amount of readthrough at one or more of the Rho- 
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Figure 3. S, nuclease mapping of the transcripts from pES4 to compare termination in nusAIO(Cs) and nusA+ 
strains. The schematic (not drawn to scale) outlines the strategy for mapping the transcripts initiating from rrnA Pl 
and the transcripts that readthrough both the Tl and T,,, terminators. The mRNA transcripts are indicated with an 
arrowhead. The 5’-end-labeled F3’P]DNA fragment (32P indicated by *) used for hybridization is shown above the 
respective mRXA transcript’. (a) Total transcripts initiating from rrnA Pl. A 330 bp HindIIIIEcoRI fragment 5’-end- 
labeled at the Hind111 site was hybridized with increasing amounts of RNA extracted from either the nusA+ strain (A) 
or the nuvAIO(Cs) strain (a), digested with S, nuclease and electrophoresed on a 1296 (w/v) polyacrylamide gel 
containing 50% (w/v) urea. The radioactivity in the protected fragment (30 bp) was quantified by counting the excised 
fragments in 5 ml of scintillation fluid (EcoLite). The amount of transcript hybridized is plotted versus increasing 
amounts of total cellular RNA. (b). Transcripts extending beyond terminators rrnB Tl and Trs,. A 1020 bp SnaBII 
&oRI fragment 5’.end-labeled at the SnaBI site was used for hybridization with RNA from either the nu.sA+ strain 
(A) or nusAIO(Cs) strain (0). After S, nuclease digestion and electrophoresis on a 5% (w/v) polyacrylamide gel 
containing 50% (w/v) urea, the protected fragment was quantified by measuring the radioactivity in the fragment. The 
amount of transcript hybridized is plotted versus increasing amounts of total cellular RNA. 
dependent or Rho-independent terminators on defect of nusA1 or the termination defect of 
which their effects were determined (Jin et al.. nusA10(Cs) and nusAIZ(Ts). The phenotypes of the 
1988). Enhanced terminator readthrough may Rif mutations, summarized in Table 8, indicate 
account for the incompatibility of these mutations that they affect both termination and 
with the nusA mutants defective in termination. antitermination processes involving NusA protein. 
4. Discussion 
We have investigated the effects of 17 Rif’ 
mutations on processes involving the NusA protein. 
We determined whether any of the Rif mutations 
alter the ability of RNA polymerase to carry out 
AN-mediated or cellular antitermination. In 
addition, we have determined whether the presence 
of the Rif’ mutations affected the antitermination 
In the discussion below, we first analyze the 
nature of the altered interaction exhibited by Rif’ 
mutations with mutant nusA alleles. We then 
describe the antitermination phenotypes of the RiF 
mutations and consider the extent to which each of 
these phenotypes can be explained either by altered 
interaction with NusA or by the termination defects 
previously attributed to these alleles (Jin et al.. 
1988). In vitro studies will be required to determine 
if the mutant proteins do have the alt#ered 
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Absorbance (450 nm) 
Figure 4. Comparison of gaZK expression in mu& + and nusAIO(Cs) strains containing either plasmid pKG1810 or 
pKG1800. GalK levels in strains containing pKG1810 reflect extent of termination at T,,, interposed between P,., and 
galK in the pKG1810 while those in strains containing pKG1800 reflect initiation at. P,,[. Wild-type (CAG8102) and 
nusAIO(Cs) (CAG3844) cells containing plasmid pKG1810 (a) or pKG1800 (b) were grown at 37 “C in MS-fructose 
complete medium supplemented with ampicillin. The levels of galactokinase in nusA + (A) and nusAIO(Cs) (0) cells are 
corrected for plasmid copy number and plotted versus AIso ( see Materials and Methods). A background of [14C]Gal-P04 
(600 cts/min) was subtracted from each experimental point 
interactions postulated here or whether some of the 
in vivo phenotypes result from other perturbations 
in cellular physiology. 
(a) Interaction of NusA and Rif’ 
RNA polymerase 
We find that many of the Rif’ alleles located at 
the distal end of the Rif region (see Table 8) 
suppress the termination defects of the nusAlO(Cs) 
and the nusAll(Ts) alleles. This suggests that the 
Rif’ RNA polymerases encoded by these mutant 
alleles interact differently with the mutant NusA 
proteins than does wild-type RNA polymerase. If  
NusA binds to RNA polymerase in the Rif region 
then the mutational changes in the Rif’ mutants 
could directly affect the interaction between NusA 
and RNA polymerase and the effects we observe 
could reflect altered protein contacts between the 
two proteins. Mutations that suppress a phenotype 
by altering protein contacts are generally found to 
be allele-specific (Jarvik & Botstein, 1975). Our 
results indicate that of the seven alleles suppressing 
nusAlO(Cs), only the suppression by rpoBll1 is 
allele-specific. Of the other six alleles suppressing 
nusAlO(Cs), five also suppressed nusAll(Ts) and 
the remaining allele (rpoB3406) grew too poorly to 
be assayed in combination with nusAll(Ts). This 
genetic criterion suggests that most of the effects we 
observe may not be due to altered protein-protein 
contacts. As an alternative explanation, the 
interaction could be indirect; for example, the 
mutant RNA polymerase might interact differently 
with some signal in the transcript to change the 
conformation of the ternary complex and affect the 
activity of NusA. Regardless of whether the effect 
of the mutant RNA polymerase on NusA activity is 
direct or indirect, because NusA is involved in both 
termination and antitermination processes, such 
alterations could have profound effects on the 
transcription process. 
(b) N-mediated antitermination phenotypes 
of Rif’ mutations 
Three types of rpoB mutations affecting 
N-mediated antitermination have been described: 
(1) N-bypass mutations, which allow 2 growth in 
the absence of N-mediated antitermination (Lecocq 
& Dambly, 1976); (2) NusC mutations, which 
restrict 2 growth in otherwise wild-type cells 
(Friedman et al., 1984); and (3) Snu mutations, 
which restrict A growth in nusA7 rells at low 
temperature (32°C) (Sternberg, 1976; Baumann & 
Friedman, 1976). We have found all of these 
phenotypes among our Rif’ mutations and in 
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Table 8 
Summary of the effects of Rif’ mutations on antitermination and their interaction with nusA mutations 
rpoB allele rpoB + 3445 101 8 113 14X 30513595 2 34013402 114 344934433370 111 7 3406 
Amino acid residue affected 507. 513 513 516 516 517 522 526 529 529 531 532 533 563 564 572 687 
511 
Suppressed termination defect 
in nusAIO(Cs) ++++++ + + + + 
in nn.sAII(Ts) ++++++ + + 
N bypass for 1 plaque formation + 
Inhibition of 1 plaque formation 
in nusA + ++ 
Interfered with antitermination 
(A.T.) in nusA1 ++ + + + ++ 
Suppressed nmA1 A.T. defect ++ + + + + + + + ++ + + 
Suppressed termination defect 
in rho15 ++ ++ 
Defect in cellular antitermination 
(with pES3 system) ++ ++ ++ 
+, Has the phenotype indicated in the first column; + +, has stronger or the strongest effect on the phenotype indicated. For 
details, see the text. 
addition, we describe another class of mutation: one 
which suppresses the nusA1 defect, permitting 1 
growth at higher temperatures. We have assayed 
the effects of Rif’ mutations on N-mediated 
antitermination by determining the efficiency of 1 
plating and by quantifying N-dependent galK 
expression. These two assays showed excellent 
agreement. In addition, the use of both assays 
enabled us to determine that A plaque formation 
was inhibited when antitermination was reduced to 
about 10% of that normally observed for rpoB+ 
parental strains at 32 “C (Tables 3 and 4). 
One Rif’ mutant, rpoB3595, allowed 1 plating in 
the absence of N and is therefore an N-bypass 
mutant. Interestingly, whereas expression from AP, 
(assayed by I growth) was N-independent, expres- 
sion from 3LP, (assayed by galK expression) was 
not. The Rif501 mutation, whose known mutational 
change is identical to that in rpoB3595 (Jin & 
Gross, 1988) also shows N-independent transcrip- 
tion from IZP, but not from IP, (Lecocq & Dambly, 
1976; D. J. Jin, data not shown). The termination 
defect of rpoB3595 is probably responsible for the 
lack of N-dependence of this Rif’ mutant. Strains 
containing rpoB3595 (or rif501) were defective in 
termination at every Rho-dependent and Rho- 
independent terminator we assayed (Jin et al., 
1988). Very likely, the terminators in the IP, 
transcript are not ones that the rpoB3595 (rif501) 
mutant RNA polymerase can readthrough 
efficiently; hence antitermination is required for 
readthrough transcription from 1P,. 
Only one Rif’ mutant, rpoBll1, exhibited a 
NusC phenotype, preventing 1 growth in an 
otherwise wild-type strain at 32°C but not at 42°C. 
Although the plating phenotype is conditional, the 
defect in N-mediated antitermination is actually 
manifest at both temperatures as measured by 
GalK assay. However, the fivefold decrease in 
N-mediated antitermination at 42°C is not severe 
enough to prevent 2 growth at high temperature. 
rpoBl11 was also the only Rif’ mutation to fit the 
genetic criteria for an allele-specific suppressor of 
mutant nusA alleles: it suppressed the termination 
defects of the nusAlO(Cs) allele but not those of 
the nusAll(Ts) allele. The suppression assay for 
nusAlO(Cs) was performed at 37°C while that for 
nusAll(Ts) was carried out at 30°C. One could 
imagine that the lack of suppression of nusA11(Ts) 
resulted from a termination defect of rpoBll1 at 
30°C. This is not the case. Strains containing 
rpoBl1 I show normal termination efficiency at 
these terminators in the presence of wild-type 
nusA + (D. J. Jin, unpublished data). If the 
rpoBll1 allele defines a protein-protein contact 
between NusA and RNA polymerase, then an 
altered contact between the two proteins could be 
responsible for the NusC phenotype exhibited by 
this allele. 
Five Rif’ alleles (rpoBll1, rpoB3445, rpoB8, 
rpoBl13, and rpoB148) inhibit I plating on nusA1 
strains at low temperatures. The fact that rpoBll1 
affects antitermination on both nusA+ and nusA1 
strains while the effect of the other alleles is limited 
to nusA1 strains could simply reflect quantitative 
differences in the antitermination defect. The 
rpoBll1 mutation restricted antitermination in the 
nusA1 strain much more severely than rpoB3445, 
the most restrictive of the four alleles affecting only 
nusA1 strains. On the other hand, there may be a 
qualitative difference between the mechanism of 
inhibition by rpoBll1 and the other four alleles. 
The four alleles affecting antitermination only in 
nusA1 strains could be having an effect that is 
possible only in the presence of the defective nusA 
allele. The idea that these mutations may have a 
qualitatively different effect from rpoBll1 is 
supported by their termination phenotypes. The four 
alleles whose effect is limited to the nusA1 strain 
map near each other (Jin &I, Gross, 1988; see also 
Table 8) and increase termination at Rho- 
dependent terminators (Jin et al., 1988). In 
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contrast, the rpoBll1 allele is actually defective in 
termination at Rho-independent terminators (Jin et 
al., 1988). Possibly, enhanced termination by the 
mutant RNA polymerases decreases antitermina- 
tion in strains with the defective nusA1 allele 
without affecting antitermination in the wild-type 
strain. rpoB111, on the other hand, must affect 
antitermination in some other way, perhaps 
through altered interaction of RNA polymerase 
with NusA. 
The class of RNA polymerase mutations partially 
suppressing the nusA1 restriction of N-mediated 
antitermination at high temperatures has not been 
previously described. Two mutations, rpoB101 and 
rpoB3370, suppress nusA2 more than tenfold, while 
nine others suppress the defect several-fold. Of the 
11 mutations suppressing the nusA1 defect, six had 
previously been shown to decrease termination, and 
three to increase termination, while two others had 
no effect upon termination (Jin et al., 1988). Thus, 
there does not seem to be a close correlation 
between these termination and antitermination 
phenotypes. 
rpoBlO1 and rpoB3370, the two Rif’ mutations 
that suppress the nusA1 phenotype most efficiently, 
are the only RIP mutations that suppress the 
termination defect of rho15 (Das et al., 1978; Jin et 
al., 1988; Table 8). These two phenotypes may arise 
from the same defect in RNA polymerase. Either 
the alteration in RNA polymerase partially com- 
pensates for the defects in nusA1 and rho15 and 
bypasses the need for these proteins, or suppression 
results from altered interactions in the ternary 
complex. 1% vitro experiments indicate that RNA 
polymerase from rpoBlO1 does not simply bypass 
the need for Rho. The mutant RNA polymerase 
does not terminate by itself. Instead, it restores the 
ability of Rho15 to hydrolyze ATP and terminate 
(Das et al., 1978) suggesting that suppression results 
from altered interactions in the ternary complex. 
Because NusA is known to bind to RNA poly- 
merase and modify its termination properties, it is 
appealing to consider the possibility that suppres- 
sion of rho15 might be mediated by altered 
interactions with NusA. Suppression of rho15 could 
result from altered contacts between NusA and 
RNA polymerase, or from indirect effects, possibly 
mediated by altered interactions of the ternary 
complex with the transcript. 
(c) Cellular antitermination phenotypes 
of Rifr mutations 
This study has identified three Rif’ mutations 
that cause a defect in cellular antitermination. 
These are the first, RNA polymerase mutations 
affecting this process to be identified. These 
mutations alter amino acids 531 (rpoBll4), 532 
(rpoB3449) and 533 (rpoB3443) in the /? poly- 
peptide. Our assay indicates that each of these 
mutations decreases the ability of the cellular 
antitermination system to readthrough the strong 
rrnT1 and T,,, terminators carried in plasmid pES3 
(Table 6). The fact that these mutations are highly 
clustered and have similar effects upon cellular 
antitermination suggests that this region of RNA 
polymerase plays a crucial role in cellular 
antitermination. 
We do not think that the plasmid pES3 vector 
necessarily provides an accurate measure of the 
extent to which cellular antitermination is altered. 
First, the boxA site in the plasmid is mutant, which 
decreases the efficiency of the antitermination 
system significantly (M. Cashel, data not shown). 
Second, the terminators in pES3 differ from those 
in the ribosomal RNA transcripts. The stable RNA 
transcript does not contain the IS2 terminator and 
not all rrn operons contain the Tl terminator. The 
effects on antitermination we observed may well 
reflect the particular terminators chosen to assay 
this process. These differences may explain why 
mutations apparently inhibiting expression of 
stable RNA so severely are still viable. 
The three Rif * mutations that are defective in the 
cellular antitermination system involved in stable 
RNA synthesis could work either by decreasing 
antitermination or increasing termination. Our 
experiments suggest that the latter is the case. 
Although these Rif’ mutations do not affect 
termination at Rho-dependent or Rho-independent 
terminators (Jin et al., 1988), they were the only 
Rif r alleles that completely restored termination to 
strains containing the nusAlO(Cs) or the 
nusAll(Ts) allele. It seems likely that the altered 
interaction of these Rif’ mutations at NusA- 
dependent terminators such as rrnA Tl uncovered 
in the mutant nusA strains is responsible, at least in 
part, for their antitermination defect. 
In summary, we have determined that alterations 
in the Rif’ region of the /I subunit of RNA 
polymerase have effects on both N-mediated 
antitermination and the cellular antitermination 
system involved in expression of stable RNA. Many 
alterations in this region of the protein also alter 
the phenotypes of several nusA alleles, suggesting 
an interaction, either direct or indirect, between 
this region of p and NusA. The effects of some of 
the Rif’ mutations on antitermination may be 
explained by the termination capabilities of RNA 
polymerase containing the mutant /3 subunit. Other 
effects on antitermination are not correlated with 
the termination phenotypes of the RIP alleles. 
These effects may be explained by altered inter- 
actions with NusA protein or with some other 
component of the antitermination apparatus. 
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